版本:
中国

BRIEF-Sangamo's genome editing program to transfer to Biogen's spin-off Bioverativ

Nov 30 Sangamo Biosciences Inc :

* Sangamo's genome editing program for hemoglobinopathies to transfer to biogen's spin-off bioverativ

* Sangamo's genome editing program for hemoglobinopathies to transfer to biogen's spin-off bioverativ Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐